Large-scale integrated analysis of ovarian cancer tumors and cell lines identifies an individualized gene expression signature for predicting response to platinum-based chemotherapy

A novel lncRNA-focus expression signature for survival prediction in endometrial carcinoma

(2018) Meng Zhou et al.   BMC CANCER

Ovarian cancer statistics, 2018

(2018) Lindsey A. Torre et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Ki-67 Contributes to Normal Cell Cycle Progression and Inactive X Heterochromatin in p21 Checkpoint-Proficient Human Cells

(2017) Xiaoming Sun et al.   MOLECULAR AND CELLULAR BIOLOGY

The Prognostic 97 Chemoresponse Gene Signature in Ovarian Cancer

(2017) Abel Matondo et al.   Scientific Reports

Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non–Small Cell Lung Cancer

(2017) Bailiang Li et al.   JAMA Oncology

Complex Determinants of Epithelial: Mesenchymal Phenotypic Plasticity in Ovarian Cancer

(2017) Yuliya Klymenko et al.   Cancers

Homologous recombination deficiency and ovarian cancer

(2016) Jonathan A. Ledermann et al.   EUROPEAN JOURNAL OF CANCER

Prediction of chemo-response in serous ovarian cancer

(2016) Jesus Gonzalez Bosquet et al.   Molecular Cancer

Targeting DNA Replication Stress for Cancer Therapy

(2016) Jun Zhang et al.   Genes

Ovarian cancer

(2016) Ursula A. Matulonis et al.   Nature Reviews Disease Primers

Prediction of resistance to chemotherapy in ovarian cancer: a systematic review

(2015) Katherine L Lloyd et al.   BMC CANCER

ZEB1: At the crossroads of epithelial-mesenchymal transition, metastasis and therapy resistance

(2015) Peijing Zhang et al.   CELL CYCLE

Homologous Recombination Deficiency: Exploiting the Fundamental Vulnerability of Ovarian Cancer

(2015) P. A. Konstantinopoulos et al.   Cancer Discovery

Inflammation-Induced Cell Proliferation Potentiates DNA Damage-Induced Mutations In Vivo

(2015) Orsolya Kiraly et al.   PLoS Genetics

Epithelial-mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients

(2014) T. Z. Tan et al.   EMBO Molecular Medicine

Correlation between gene expression and mutator phenotype predicts homologous recombination deficiency and outcome in ovarian cancer

(2014) Jianping Lu et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Epithelial–mesenchymal status renders differential responses to cisplatin in ovarian cancer

(2014) Q H Miow et al.   ONCOGENE

microRNA-181a has a critical role in ovarian cancer progression through the regulation of the epithelial–mesenchymal transition

(2014) Aditya Parikh et al.   Nature Communications

BRCA1- and BRCA2-related mutations: therapeutic implications in ovarian cancer

(2013) B. Pothuri   ANNALS OF ONCOLOGY

Resistance to platinum-based chemotherapy is associated with epithelial to mesenchymal transition in epithelial ovarian cancer

(2012) Sergio Marchini et al.   EUROPEAN JOURNAL OF CANCER

A DNA Repair Pathway–Focused Score for Prediction of Outcomes in Ovarian Cancer Treated With Platinum-Based Chemotherapy

(2012) Josephine Kang et al.   JNCI-Journal of the National Cancer Institute

Multi-Gene Expression Predictors of Single Drug Responses to Adjuvant Chemotherapy in Ovarian Carcinoma: Predicting Platinum Resistance

(2012) J. Stuart Ferriss et al.   PLoS One

Elevated Expression of the Serine-Arginine Protein Kinase 1 Gene in Ovarian Cancer and Its Role in Cisplatin Cytotoxicity In Vitro

(2012) Kunle Odunsi et al.   PLoS One

Isolation and Characterization of Tumor Cells from the Ascites of Ovarian Cancer Patients: Molecular Phenotype of Chemoresistant Ovarian Tumors

(2012) Ardian Latifi et al.   PLoS One

A seven-gene prognostic model for platinum-treated ovarian carcinomas

(2011) R Sabatier et al.   BRITISH JOURNAL OF CANCER

Acquisition of Chemoresistance and EMT Phenotype Is Linked with Activation of the Endothelin A Receptor Pathway in Ovarian Carcinoma Cells

(2011) L. Rosano et al.   CLINICAL CANCER RESEARCH

Association of BRCA1 and BRCA2 Mutations With Survival, Chemotherapy Sensitivity, and Gene Mutator Phenotype in Patients With Ovarian Cancer

(2011) Da Yang et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Integrated genomic analyses of ovarian carcinoma

(2011) D. Bell et al.   NATURE

Integrated analysis of DNA methylation and gene expression reveals specific signaling pathways associated with platinum resistance in ovarian cancer

(2009) Meng Li et al.   BMC Medical Genomics

Snail and Slug Mediate Radioresistance and Chemoresistance by Antagonizing p53-Mediated Apoptosis and Acquiring a Stem-Like Phenotype in Ovarian Cancer Cells

(2009) Nawneet K. Kurrey et al.   STEM CELLS

Global gene expression analysis of early response to chemotherapy treatment in ovarian cancer spheroids

(2008) Sylvain L'Espérance et al.   BMC GENOMICS

The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2

(2008) S.-M. Park et al.   GENES & DEVELOPMENT